Ultragenyx Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.About RARE
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.
CEOEmil D. Kakkis
CEOEmil D. Kakkis
Employees1,294
Employees1,294
HeadquartersNovato, California
HeadquartersNovato, California
Founded2010
Founded2010
Employees1,294
Employees1,294
RARE Key Statistics
Market cap3.53B
Market cap3.53B
Price-Earnings ratio-6.15
Price-Earnings ratio-6.15
Dividend yield—
Dividend yield—
Average volume1.35M
Average volume1.35M
High today$37.25
High today$37.25
Low today$35.99
Low today$35.99
Open price$36.46
Open price$36.46
Volume1.24M
Volume1.24M
52 Week high$50.00
52 Week high$50.00
52 Week low$25.81
52 Week low$25.81
Stock Snapshot
Ultragenyx Pharmaceutical(RARE) stock is priced at $35.99, giving the company a market capitalization of 3.53B. It carries a P/E multiple of -6.15.
During the trading session on 2025-12-04, Ultragenyx Pharmaceutical(RARE) shares reached a daily high of $37.25 and a low of $35.99. At a current price of $35.99, the stock is 0.0% higher than the low and still -3.4% under the high.
Trading activity shows a volume of 1.24M, compared to an average daily volume of 1.35M.
The stock's 52-week range extends from a low of $25.81 to a high of $50.00.
The stock's 52-week range extends from a low of $25.81 to a high of $50.00.
Analyst ratings
95%
of 21 ratingsBuy
95.2%
Hold
4.8%
Sell
0%
People also own
Based on the portfolios of people who own RARE. This list is generated using Robinhood data, and it’s not a recommendation.